Trial intelligence / Profile preview

Booster-dose vs standard-dose influenza vaccination in lupus patients

TCTR20230610003Phase 3Completed

Sponsor
Mahidol University
Start
May 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of influenza vaccine in influenza, sponsored by Mahidol University. Started May 2021; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on TCTR20230610003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230610003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call